The latter promotes the recruitment of N2 TANs, which express PD-L1 and interact with the PD−1 receptor on CD8+ T cells, thereby suppressing the anti-tumor immune response and facilitating immune evasion. The gene discussed is CD8A; the disease is neoplasm.